$BNTX $PFE. #BioNTech and #Pfizer announce completion of dosing for first cohort of Phase 1/2 trial of COVID-19 vaccine candidates in Germany https://t.co/mebEzFP5Ef. #BNT162 #mRNA #vaccines #SARSCoV2 #COVID19 #coronavirus